IP Library Granted Patent US 7,048,858
Granted Patent B2
US 7,048,858 · App. 10/496,762 · Granted May 23, 2006

Post-modification of a porous support

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,048,858
App. No.
10/496,762
Granted
May 23, 2006
Kind
B2
Abstract

The present invention relates to a method for post-modification of a porous polymeric polysaccharide support comprising one or more unreacted double bonds, which method includes to contact the polymeric support with a liquid phase comprising at least one grafting compound and to initiate a free radical reaction in the mixture obtained, wherein the grafting compound is comprised of a double bond as a reactive group coupled to a linear or cyclic chain of carbon, which optionally comprises one or more heteroatoms. An advantageous grafting compound is a vinyl ether or a hydroxyvinyl ether. The invention also encompasses a polymeric support that has been post-modified by the method according to the invention as well as the use of such a support, e.g. in chromatography.

Claims (22)

1. A method for post-modification of a porous polymeric polysaccharide support including one of more unreacted double bonds, said method comprising

(a) contacting the polymeric support with a liquid phase comprising at least one grafting compound;

(b) initiating a free radical in the mixture obtained from step (a) between one or more double bonds on said polymeric support and one or more reactive groups on the grafting compound, and optionally

(c) washing the polymeric support to remove any excess of grafting compound;

wherein at least one grafting compound is represented by the general formula (I) below:

wherein

R=a C 1 to C 30 alkyl chain, optionally substituted with one or more hydroxyl, amine, carbonyl, ether, or oxygen;

R′=H or CH 3 ;

R″=a C 0 to C 30 alkyl chain or oxygen; and

X=O n , wherein n is an integer of 0–1, with the proviso that if R″ is oxygen, then n is 0, and if R″ is an alkyl chain, then n is 1.

2. The method of claim 1 , wherein the porous polymeric polysaccharide support is chemically cross-linked.

3. The method of claim 1 , wherein the reactive double bonds present on the polysaccharide have been provided by treatment thereof with a functional epoxide.

4. The method of claim 1 , wherein the support is comprised of one or more particles.

5. The method of claim 1 , wherein step (b) is performed by adding a free radical initiator in an amount sufficient to polymerise added grafting compound to the polymeric support.

6. The method of claim 1 , wherein in formula (I), R is a C 1 –C 10 alkyl chain, R′ is H, R″ is O and n is the integer 0.

7. The method of claim 1 , wherein in formula (I), R is a C 17 alkyl chain.

8. The method of claim 1 , wherein in formula (I), R is a C 1 –C 10 alkyl chain, R′ is H, R″ is CH 2 and n is the integer 1.

9. The method of claim 1 , wherein at least one grafting compound comprises one or more hydrophilic groups, which method comprises a further step for derivatisation of said hydrophilic group(s).

10. The method of claim 1 , wherein at least one grafting compound comprises one or more functional groups in addition to the reactive double bond, which functional group is available as a ligand on the surface of the so modified support.

11. A process for providing a separation medium with a predetermined hydrophobicity comprising the method of post-modification of claim 1 , wherein at least two grafting compounds of different hydrophobicity are used.

12. The process of claim 11 , wherein a first grafting compound is a hydroxy alkyl vinyl ether and a second grafting compound is a vinyl alkyl ether.

13. The process of claim 11 , wherein a first grafting compound is represented by formula (I) and a second grafting compound is a functional monomer of lower or higher hydrophobicity than the first grafting compounds.

Assignments (4)
CHANGE OF NAME Recorded Oct 5, 2020
From: GE HEALTHCARE BIOPROCESS R&D AB
To: CYTIVA BIOPROCESS R&D AB
Reel/Frame 054299/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2016
From: GE HEALTHCARE BIO-SCIENCES AB
To: GE HEALTHCARE BIOPROCESS R&D AB
Reel/Frame 038811/0001 →
CHANGE OF NAME Recorded Feb 21, 2006
From: PHARMACIA FINE CHEMICALS AB; PHARMACIA LKB BIOTECHNOLOGY AB; PHARMACIA BIOTECH AB; APBIOTECH AB; AMERSHAM PHARMACIA BIOTECH AB; AMERSHAM BIOSCIENCES AB
To: GE HEALTHCARE BIO-SCIENCES AB
Reel/Frame 017186/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2004
From: IHRE, HENRIK
To: AMERSHAM BIOSCIENCES AB
Reel/Frame 015754/0376 →